ACP hosts 'Internal Medicine 2007' in San Diego

March 21, 2007

PHILADELPHIA, March 21, 2007 - The American College of Physicians (ACP), the leading professional organization for internal medicine, has a new name for its annual meeting: "Internal Medicine 2007." The annual ACP scientific meeting, formerly known as Annual Session, takes place April 19-21 in San Diego and offers more than 260 educational courses covering the latest advances in the field of internal medicine and its subspecialties such as cardiology and gastroenterology.

With more than 6,000 internists, medical students, and other health care professionals expected to attend, Internal Medicine 2007 is the largest continuing education meeting for internists (doctors of internal medicine), who specialize in the prevention, detection, and treatment of illness in adults.

According to ACP data, more than 75 percent of the general and subspecialty internists attending the meeting are involved in the direct care of patients. Internal medicine physicians provide care for both acute and chronic diseases. More than half of the nation's adults consider an internist as their primary care physician.

Internal Medicine 2007 course topics range from vital clinical issues such as diabetes, heart disease, hypertension, obesity, avian flu, and community-acquired MRSA infections; to important social and interpersonal aspects of caring for adults such as counseling patients who ask about cosmetic procedures, eating disorders, sexually transmitted diseases, ADHD in adults, and health literacy; to contemporary topics such as disaster preparedness.

Three special learning tracks are available to attendees. The Core Topics Track is designed for subspecialists who find it difficult to keep up with the clinical topics outside of their subspecialties. This track identifies a series of sessions covering many of the "core" topics in internal medicine that are useful to all internists, independent of specialty. The Hospitalist Track includes medical consultation, end-of-life care, patient safety, and teaching house staff. The Diabetes Track offers attendees the opportunity to update their knowledge of this illness and its many complications.

For physicians interested in interactive learning, the Herbert S. Waxman Learning Center offers hands-on activities and clinical demonstrations focusing on communication, physical examination, and procedural skills.

The opening ceremony on Thursday morning, April 19, features Carolyn M. Clancy, MD, MACP, Director, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, delivering the keynote address, entitled "Achieving Quality and Patient-centered Care: Making Tomorrow's Goals Today's Reality."

The annual Convocation ceremony on Thursday evening recognizes new Fellows, Honorary Fellows, Masters, and award recipients. Through its awards, the College recognizes accomplishments in medical practice, teaching, research, volunteer service, preventive medicine, and other areas.
The American College of Physicians ( is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 120,000 internal medicine physicians (internists), related subspecialists, and medical students. Internists specialize in the prevention, detection, and treatment of illness in adults.

ACP was founded in 1915 to promote the science and practice of medicine. In 1998 it merged with the American Society of Internal Medicine, which was established in 1956 to study economic aspects of medicine. ACP works to enhance the quality and effectiveness of health care by fostering excellence and professionalism in the practice of medicine.

American College of Physicians

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to